Some people come home from a beach vacation and notice their skin looks clear and glowy. It's not their imagination. Unlike ...
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...
Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...
Sicca is not a feature of RA. Psoriatic arthritis (PSA) is a type of arthritis linked to the autoimmune skin condition ...
Meteorological factors accounted for less than 1% of the variation in patient-reported outcomes among individuals with psoriatic arthritis. Meteorological factors may account for less than 1% of the ...